CalciMedica
CALC
25 hedge funds and large institutions have $6.27M invested in CalciMedica in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 3 closing their positions.
2,840% more call options, than puts
Call options by funds: $147K | Put options by funds: $5K
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
0% more funds holding
Funds holding: 25 → 25 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
13% less capital invested
Capital invested by funds: $7.17M → $6.27M (-$905K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$150K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$52.6K |
| 3 |
Jane Street
New York
|
+$11.6K |
| 4 |
Morgan Stanley
New York
|
+$3.03K |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$1.26K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$50.6K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$34.3K |
| 3 |
Two Sigma Investments
New York
|
-$19K |
| 4 |
LCS
Levin Capital Strategies
New York
|
-$16K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$16K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| – | +$14 | +1 | +17% |
|
27
Simplex Trading
Chicago,
Illinois
| – | +$764 | +54 | +360% |
|
CALC Hedge Fund Activity: Q3 2022 in Review
25 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q3 2022, worth a combined $6.27M — down 13% from $7.17M a quarter earlier.
Fund positioning in CALC was balanced in Q3 2022: 3 funds opened new positions, 3 closed out, 6 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $150K. The largest seller was Bridgeway Capital Management, cutting an estimated $50.6K.
- 25 institutional investors held CalciMedica (CALC) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $6.27M of CalciMedica stock for Q3 2022, down 13% quarter-over-quarter.
- 3 funds opened new CalciMedica positions in Q3 2022 and 3 closed out, a net change of 0 holders.
- The largest CalciMedica buyer in Q3 2022 was Renaissance Technologies, an estimated $150K added.
- The largest CalciMedica seller in Q3 2022 was Bridgeway Capital Management, an estimated $50.6K sold.
Based on aggregated 13F filings for Q3 2022.